Estimates Revisions Verastem, Inc.

Stocks

Market Closed - Nasdaq 23:00:00 18/08/2026 +03			5-day change	1st Jan Change
7.430 ^USD	+3.48%		+5.39%	-3.76%

08-11	Mizuho Adjusts Price Target on Verastem to $13 From $14, Keeps Outperform Rating	MT
08-07	Verastem, Inc. Amends Note Purchase Agreement to Establish New Series of Senior Secured Revenue Notes Up to $75 Million	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	VERASTEM, INC.
	WUXI APPTEC CO., LTD.
	ARGENX SE
	INSMED INCORPORATED
	WUXI BIOLOGICS (CAYMAN) INC.
	BIONTECH SE
	PHARMAESSENTIA CORPORATION
	GENMAB A/S
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
	EXELIXIS, INC.
	Average
	Weighted average by Cap.